GEO Accession viewer

NCBI > GEO > Accession Display

Not logged in | Login

GEO help: Mouse over screen elements for information.

Series GSE3720

Query DataSets for GSE3720

Status

Public on Feb 28, 2006

Title

Distinct gene expression in human Vd1 and Vd2 gd T cells following non-TCR agonist stimulation

Organism

Homo sapiens

Experiment type

Expression profiling by array

Summary

The two major human gd T cell subsets, Vd1 and Vd2, display differences in tissue tropism and agonist responses, but we have little insight into global differences that may exist at the gene expression level. This is due to the small numbers of these cells that can be obtained from healthy donors, which limit comprehensive, comparative gene expression analyses. We established a culture method that expands Vd1 and Vd2 cells from the same PBL preparation to levels sufficient for sorting and microarray analysis. Although the subsets were expanded identically (anti-TCR mAb, plus IL-15), 392 and 614 genes were identified, which were differentially expressed in the two subsets, from two donors, respectively. Approximately 4,500 genes changed in both subsets following PMA/ionomycin treatment; about 50% of these genes were subset-specific. Both subsets responded to a crude LPS preparation, but only 6% of the responsive genes were the same. The differentially expressed genes were consistent with Vd2 cells being more inflammatory and Vd1 cells having more of a regulatory phenotype. Both subsets expressed transcripts encoding an array of innate and NK cell receptors, supporting the relationship of gd?T cells to the innate immune system. Our results show that circulating Vd1 and Vd2 subsets in humans have considerable, inherent differences in gene expression following treatment with non-TCR agonists, supporting unique functional roles for these cells in vivo.
Keywords: cell type comparison

Overall design

To analyze global gene expression differences between Vd1 and Vd2 gd T cells, 12 Affymetrix Human Genome U133A 2.0 chips were run. 2 replicate sets of 6 chips from 2 donors were run; each set of six chips consisted of 3 chips for Vd1 cells and 3 chips for Vd2 cells. The 3 chips for each subset consisted of cells treated with PBS, LPS, or PMA/ionomycin for 4 hours just prior to RNA extraction.

Contributor(s)

Kress E, Hedges JF, Jutila MA

Citation(s)

16423401

Submission date

Dec 02, 2005

Last update date

Dec 06, 2018

Contact name

Ellen Kress

E-mail(s)

[email protected]